Merck & Co., Inc.
$145.00
-0.2%(24h)Today
-0.2%
30 Days
0.5%
Price Change (24h)
-$0.2615
Today
-0.2%
30 Days
0.5%
Price Change (24h)
-$0.2615
The live price of Merck & Co., Inc. is $145.00 per RMRK/USD, -0.18% in the last 24 hours. It has a market cap of — and $1.17B in trading volume over the same period. Prices are averaged across every exchange we track and update continuously.
Current price
$145.0024h high
$147.8024h low
$144.2824h
-0.18%7d
-0.25%30d change
-0.82%Rank
—
Market Cap
—
24h Volume
$1.17B
Across 1 exchanges
FDV
—
Circulating Supply
—
Total Supply
—
Max Supply
—
No fixed cap
Listed on
1 exchanges
The asset this tracks
Company
Merck & Co., Inc.
Ticker
MRK
Share price
$151.70
Company market cap
$374.26B
RMRK vs MRK
-4.41%
Shares trade only during market hours while this token trades continuously, so the comparison uses the last available share price. Updated Sep 3, 2026.
What is a tokenized stock?
RMRK is a crypto token whose price tracks Merck & Co., Inc. (MRK) shares. It is not the share itself. How it is structured depends on the issuer — some tokens are backed one-for-one by real shares held in custody, others are synthetic and simply follow the price. Check the issuing exchange's terms before trading.
Holding a tokenized stock does not usually grant shareholder rights — no voting, and dividends are handled differently or not at all. You are exposed to the issuer and the exchange as well as to the share price.
Information only, not investment advice. Tokenized equities carry issuer and counterparty risk, and availability is restricted in many jurisdictions.
Merck & Co., Inc. is available on 1 exchanges. Prices shown are live.
| Exchange | Pair | Volume | Trade |
|---|---|---|---|
| Bitget | RMRKUSDT | — | Buy RMRK on Bitget |
We may earn a commission when you sign up through these links. This never affects the prices shown.
Trade RMRK with virtual money. Nothing here is a real order, and no deposit is ever taken.
Trade RMRK risk-free
Buy and sell Merck & Co., Inc. at live market prices using virtual cash.
Track your portfolio
Watch profit and loss update against real prices, position by position.
Climb the leaderboard
Your returns are ranked against every other player in the league.
Free to play
No deposit, no card, no real funds at risk — just an account.
Merck & Company, Inc. is a global healthcare company that develops and sells a wide range of pharmaceutical products for human health. Its portfolio includes treatments and vaccines for various medical conditions, marketed under numerous brand names. The company also offers veterinary pharmaceuticals, vaccines, and health management solutions for livestock and companion animals, along with related identification and monitoring services.
The company engages in multiple external collaborations to expand its pipeline. These include agreements with Daiichi Sankyo for certain cancer drug candidates, a co-development and co-commercialization arrangement with AstraZeneca for cancer therapies, and a licensing deal with LaNova for an investigational antibody. Additional partnerships cover collaborations with Eisai, Bayer, Ridgeback Biotherapeutics, Moderna, and a strategic alliance with Infinimmune for antibody discovery.
Founded in 1891, Merck & Company, Inc. is headquartered in Rahway, New Jersey, and operates worldwide.